| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a78c5bf69b40d464b954ef76815c6fa0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09778bc31b651e722926b6ac7cfce364 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2001-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcd590c84c6caef66e55dcd25b063c4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eec2891a494ead3f46bed3bf1ab8d0d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8e755d6bf58f0feafba41681d24d799
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50cdcc01f4db36bcddd3845a54294a7a |
| publicationDate |
2003-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2196334-C2 |
| titleOfInvention |
Method for diagnosing progredient course of cerebral injury disease |
| abstract |
FIELD: medicine. SUBSTANCE: method involves applying immunoenzyme analysis method for determining TNF and IL cytokine level in patient blood serum at the end of recovery period. TNF cytokine level being greater than 16.8 pg/ml and IL cytokine level being less than 97.88 pg/ml, progredient cerebral injury disease development course is to be predicted. EFFECT: enhanced accuracy of diagnosis in early development period. 2 tbl |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2559587-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2615354-C1 |
| priorityDate |
2001-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |